Skip to main content
Log in

Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Legrand M, Michel T, Daudon M, Benyamina M, Ferry A, Soussi S, Maurel V, Chaussard M, Chaouat M, Mimoun M, Verine J, Mallet V, Mebazaa A, PRONOBURN Study Group (2016) Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. doi:10.1007/s00134-016-4252-4

    PubMed  Google Scholar 

  2. CYANOKIT® Hydroxocobalamin. Product monograph. http://www.medical-information.ca/wp-content/uploads/2015/07/CYANOKIT-HCP.pdf. Accessed 4 April 2016

  3. Thompson JP, Marrs TC (2012) Hydroxocobalamin in cyanide poisoning. Clin Toxicol (Phila) 50:875–885

    Article  CAS  Google Scholar 

  4. Borron SW, Stonerook M, Reid F (2006) Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 44(Suppl 1):5–15

    Article  CAS  Google Scholar 

  5. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C (2007) Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 49:794–801

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruno Mégarbane.

Ethics declarations

Conflicts of interest

The author declares no conflict of interest.

Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mégarbane, B. Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation. Intensive Care Med 42, 1197–1198 (2016). https://doi.org/10.1007/s00134-016-4354-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-016-4354-z

Keywords

Navigation